HPAE-FLD Method for Separation of 2-Aminobenzamide (2-AB)-Labeled Oligosaccharides from Human α1 Acid-Glycoprotein and Bovine Fetuin

Significance of the topic

Glycosylation is a critical post translational modification affecting protein folding function and therapeutic efficacy
N linked glycans on proteins such as alpha1 acid glycoprotein and fetuin influence biological activity and require accurate profiling for quality control of biopharmaceuticals
High performance anion exchange chromatography with fluorescence detection provides selective and sensitive glycan analysis

Objectives and Study Overview

• Demonstrate the proposed USP General Chapter 212 HPAE FLD method for separation of 2 AB labeled N linked oligosaccharides
• Compare two purification techniques namely SEC spin columns and SPE cartridges
• Evaluate two gradient elution schemes unmodified and modified conditions

Methodology and Instrumentation

The released N linked oligosaccharides from human alpha1 acid glycoprotein and bovine fetuin were labeled with 2 aminobenzamide using a standard kit under controlled conditions. Free dye was removed using either size exclusion spin columns packed with G10 resin or glyco clean solid phase extraction cartridges. Purified labeled glycans were dried reconstituted and analyzed.

Two gradient elution programs were tested using a Thermo Scientific Dionex CarboPac PA1 analytical column with hydroxide based eluents and a fluorescence detector set at 330 nm excitation and 420 nm emission. Unmodified conditions used water sodium acetate and sodium hydroxide while modified conditions included 0.05 N sodium hydroxide in the acetate eluent to reduce microbial contamination.

Instrumentation Used

• Dionex ICS 5000 plus RFIC system with dual pump and degasser module
• Thermo Scientific Ultimatego 3000 RS fluorescence detector with 8 ul flow cell
• CarboPac PA1 analytical 4×250 mm column with 4×50 mm guard
• G10 SEC spin columns and GlycoClean S SPE cartridges
• Standard lab equipment including centrifuge autosampler and microcentrifuge tubes

Main Results and Discussion

The retention profiles of mono di tri and tetra sialylated glycans designated S1 S2 S3 and S4 were consistent across both purification methods and elution schemes. Average retention times and relative retention times relative to S4 differed by less than 1 in all cases confirming method robustness. Both human alpha1 acid glycoprotein and bovine fetuin samples yielded reproducible chromatographic profiles under unmodified and modified conditions indicating that the minor eluent modification does not affect glycan separation. These findings support the suitability of the USP 212 method for routine glycan profiling.

Benefits and Practical Application of the Method

• High sensitivity and selectivity for N linked glycans labeled with 2 AB
• Flexibility in sample clean up by SEC or SPE without altering results
• Adaptable eluent composition to limit microbial growth while preserving performance
• Seamless integration into biopharmaceutical QA QC workflows for glycan profiling

Future Trends and Potential Applications

• Extension to more complex glycoprotein therapeutics and glycan heterogeneity studies
• Coupling with mass spectrometry for structural confirmation alongside FLD quantitation
• Development of high throughput automation for increased sample throughput
• Integration with advanced data analysis software and glycomics databases for streamlined interpretation

Conclusion

The presented HPAE FLD method provides a robust streamlined approach for analyzing 2 AB labeled N linked oligosaccharides. Minimal impact of purification and eluent variations on glycan retention demonstrates method resilience. This protocol fulfils the requirements of USP General Chapter 212 and can be employed for routine glycan profiling in protein therapeutic development and quality control.

References

1. Spiro RG Glycobiology 2002 12 4 43R
2. Bechor DS Levy Y PNAS 2008 105 24 8256
3. Brandley BK Schnaar RL Journal of Leukocyte Biology 1986 40 97
4. USP General Chapter 212 Oligosaccharide Analysis Pharmacopeia Forum 2014 40 3
5. Rohrer JS Basumallick L Hurum D Biochemistry Moscow 2013 78 697 709
6. Dionex Technical Note 71 Sunnyvale CA Eluent Preparation for HPAE PAD